Leucine-rich repeat transmembrane protein 2 (LRRTM2) emerged as a key protein associated with both SGLT2 inhibition and HF, and the results showed that SGLT2 inhibition decreased the risk of HF. The gene discussed is LRTM2; the disease is hydrops fetalis.